INTERSTICIAL PNEUMONITIS, CAUSED BY PEGYLATED INTERFERON ALFA-2A IN A 4 MONTHS CHILD WITH GIGANTIC KAPOSI'S HAEMANGIOEPITHELIOM AND KASABACH – MERRIT PHENOMENON: A CASE REPORT
Abstract
The article presents the description of a case of drug-induced lung impairment in a child.
About the Authors
S. S. PostnikovRussian Federation
Yu. A. Polyaev
Russian Federation
A. A. Mylnikov
Russian Federation
A. N. Gricianskaya
Russian Federation
M. N. Kostyleva
Russian Federation
D. V. Rogogyn
Russian Federation
References
1. Чельцов В.В., Мартынов А.И.- Лекарственное поражение легких // Клиническая фармакология и терапия.-2013.-22 (2). - Стр. 58-62.
2. Костылева М.Н. Пегинтерферон – редкий побочный эффект // Детская больница.-2012.-№3 (49).-Стр. 49.
3. S. Slavenberg, Y.F. Heijdra, Y.P.Drenth. - Pneumonitis as consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: review of the literature.-Dig.Dis.Sci.-2010. Mar; 55 (3):579-85.
Review
For citations:
Postnikov S.S., Polyaev Yu.A., Mylnikov A.A., Gricianskaya A.N., Kostyleva M.N., Rogogyn D.V. INTERSTICIAL PNEUMONITIS, CAUSED BY PEGYLATED INTERFERON ALFA-2A IN A 4 MONTHS CHILD WITH GIGANTIC KAPOSI'S HAEMANGIOEPITHELIOM AND KASABACH – MERRIT PHENOMENON: A CASE REPORT. Safety and Risk of Pharmacotherapy. 2014;(1):23-26. (In Russ.)